CD8A and neoplasm: Some of these molecules include lymphocytes’ host effector molecules such as interferon-gamma and perforin, targeting tumor cells and enhancing the cross-presentation between dendritic cells (DCs) CD103+ and CD8+ T cells, among other immune phenomena (37–40).